| Literature DB >> 19684603 |
Lisa R Treviño1, Wenjian Yang, Deborah French, Stephen P Hunger, William L Carroll, Meenakshi Devidas, Cheryl Willman, Geoffrey Neale, James Downing, Susana C Raimondi, Ching-Hon Pui, William E Evans, Mary V Relling.
Abstract
Using the Affymetrix 500K Mapping array and publicly available genotypes, we identified 18 SNPs whose allele frequency differed significantly(P < 1 x 10(-5)) between pediatric acute lymphoblastic leukemia (ALL) cases (n = 317) and non-ALL controls (n = 17,958). Two SNPs in ARID5B not only differed between ALL and non-ALL groups (rs10821936, P = 1.4 x 10(-15), odds ratio (OR) = 1.91; rs10994982, P = 5.7 x 10(-9), OR = 1.62) but also distinguished B-hyperdiploid ALL from other subtypes (rs10821936, P = 1.62 x 10(-5), OR = 2.17; rs10994982, P = 0.003, OR 1.72). These ARID5B SNPs also distinguished B-hyperdiploid ALL from other subtypes in an independent validation cohort (n = 124 children with ALL; P = 0.003 and P = 0.0008, OR 2.45 and 2.86, respectively) and were associated with methotrexate accumulation and gene expression pattern in leukemic lymphoblasts. We conclude that germline variants affect susceptibility to, and characteristics of, specific ALL subtypes.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19684603 PMCID: PMC2762391 DOI: 10.1038/ng.432
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330